Literature DB >> 4356471

Microcomplement-fixation inhibition: a rapid and economical test to detect non-complement-fixing antibodies.

R G Olsen, L E Mathes, D S Yohn.   

Abstract

Complement-fixation inhibition test was adapted to the microtiter system. When cat and monkey non-complement-fixing antibody were used, the microtest was shown to be as sensitive as the conventional tube complement-fixation inhibition test.

Mesh：

Substances：

Year:  1973        PMID： 4356471      PMCID： PMC379859          DOI： 10.1128/am.26.4.617-619.1973

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN： 0003-6919


  5 in total

1.  The demonstration of substances in human sera which inhibit complement fixation in antigen-antibody systems of lymphogranuloma venereum, psittacosis, mumps, Q fever, and lymphocytic choriomeningitis.

Authors:  N J SCHMIDT; H B HARDING
Journal:  J Bacteriol       Date:  1956-02       Impact factor: 3.490

2.  Differences in clinical and convalescent-phase antibodies of Rhesus monkeys infected with monkey pox, tanapox, and Yaba poxviruses.

Authors:  R D Hall; R G Olsen; S P Pakes; D S Yohn
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

3.  Demonstration of antibody in cat sera to feline oncornavirus by complement-fixation inhibition.

Authors:  R G Olsen; D S Yohn
Journal:  J Natl Cancer Inst       Date:  1972-08       Impact factor: 13.506

4.  Complement fixation blocking activity of anti-dengue IgM antibody.

Authors:  R M Scott; P K Russell
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

5.  The complement-fixation reaction in eguine infectious anemia: demonstration of inhibition by IgG (T).

Authors:  T C McGuire; G L Van Hoosier; J B Henson
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422
  5 in total
  1 in total

1.  Differences in acute and convalescent-phase antibodies of cats infected with feline picornaviruses.

Authors:  R G Olsen; D E Kahn; E A Hoover; N J Saxe; D S Yohn
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.